103 related articles for article (PubMed ID: 9521474)
1. Expression of rasGTPase activating protein in basal cell carcinoma of the skin.
Barshack I; Goldberg I; Davidson B; Ravid A; Schiby G; Kopolovic J; Leviav A; Friedman E
Mod Pathol; 1998 Mar; 11(3):271-5. PubMed ID: 9521474
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of Ras GTPase activating protein in human trophoblastic tumors.
Ståhle-Bäckdhal M; Inoue M; Zedenius J; Sandstedt B; DeMarco L; Flam F; Silfverswärd C; Andrade J; Friedman E
Am J Pathol; 1995 May; 146(5):1073-8. PubMed ID: 7747802
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of rasGTPase activating protein (rasGAP) in prostate cancer.
Davidson B; Agulansky L; Goldberg I; Friedman E; Ramon J; Barshack I; Kopolovic J
Pathol Res Pract; 1998; 194(6):399-404. PubMed ID: 9689648
[TBL] [Abstract][Full Text] [Related]
4. [Immunomorphological features of cutaneous basal-cell carcinoma].
Chuprov IN
Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
[TBL] [Abstract][Full Text] [Related]
5. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
6. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
9. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
12. The role of ras GTPase activating protein in human tumorigenesis.
Friedman E
Pathobiology; 1995; 63(6):348-50. PubMed ID: 8738474
[TBL] [Abstract][Full Text] [Related]
13. [Specific characteristics of skin basal cell carcinoma invasion].
Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.
Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML
Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299
[TBL] [Abstract][Full Text] [Related]
15. Proliferative characterization of basal-cell carcinoma and trichoepithelioma in small biopsy specimens.
Lum CA; Binder SW
J Cutan Pathol; 2004 Sep; 31(8):550-4. PubMed ID: 15268710
[TBL] [Abstract][Full Text] [Related]
16. p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling.
Pamonsinlapatham P; Hadj-Slimane R; Lepelletier Y; Allain B; Toccafondi M; Garbay C; Raynaud F
Biochimie; 2009 Mar; 91(3):320-8. PubMed ID: 19022332
[TBL] [Abstract][Full Text] [Related]
17. RasGTPase-activating protein is a target of caspases in spontaneous apoptosis of lung carcinoma cells and in response to etoposide.
Bartling B; Yang JY; Michod D; Widmann C; Lewensohn R; Zhivotovsky B
Carcinogenesis; 2004 Jun; 25(6):909-21. PubMed ID: 14742324
[TBL] [Abstract][Full Text] [Related]
18. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
20. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
